Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 24th Annual Needham Virtual Growth Conference.
Read More
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.
These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.
The AlphaVac system is an off the shelf, easy to assemble, emergent mechanical aspiration device, allowing for efficient procedure time…
Today, localized therapy options are limited in providing physicians and patients with a customizable and confident treatment. Most options come…
“The acquisition of Auryon brings a remarkable, foundational technology to our portfolio that will change the way caregivers deliver treatment…
It takes a team of talented people to become one of the world’s leading providers of innovative medical devices.
The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.
If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.
Thank you to Drs. Powell (IR), Gibber (CT), and Manchec (@Manchec_MD) at @BaptistHealthSF for the livestream at #ISET2022! We thank you for your continued partnership in patient care. @ISETNews #AngioVac
Risk Info: https://bit.ly/AVRiskInfo
RIGHT NOW at #ISET2022: Drs. Powell (IR), Gibber (CT), and Manchec (IR; @Manchec_MD) at @BaptistHealthSF LIVESTREAMING an #AngioVac case! Check it out at https://virtual.iset.org/media/live-case-saving-best-last @ISETNews
Risk Info: https://bit.ly/AVRiskInfo
Thank you to @flowingdoctor and Dr. Elmore from @AtriumNavicent for their continued partnership in improving patient care with the #AlphaVac System #HuntModeActivated
🩸 80 cc Blood Loss
⏱️ 21 minutes
https://bit.ly/AlphaRiskInfo
Congratulations to Dr. Jens Brock Johansen & Odense University Hospital, Denmark, on their first case with the AngioVac System! Please visit https://bit.ly/AVRiskInfo for risk information and http://www.angiovac.com for full product information. #IRTwitter #cardiotwitter #angiovac
AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.
Latham, NY (HQ)
Glens Falls, NY (Manufacturing)
Queensbury, NY (Manufacturing)
Marlborough, MA (R&D)
Amsterdam, NL (International HQ)
São Paulo, BR (Brazil Office)
Oakville, CA (Canada Office)
Hong Kong, HK (Asia Pacific Regional Office)
Rehovot, IL (Israel Office)
